Tumour-associated macrophages as a prototypic type II polarised phagocyte population: Role in tumour progression

European Journal of Cancer

Volumn 40, Issue 11, 2004, Pages 1660-1667

  Mantovani, Alberto ^a,b   Allavena, Paola ^a   Sica, Antonio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Polarised phagocyte populations; Tumour progression; Tumour associated macrophages

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CELL DIFFERENTIATION; CELL HYPOXIA; CELL POPULATION; CELL SURVIVAL; CELL TYPE; CYTOKINE RELEASE; HODGKIN DISEASE; HUMAN; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KAPOSI SARCOMA; MICROENVIRONMENT; NONHUMAN; PHAGOCYTE; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

EID: 3142644996     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.03.016     Document Type: Article

References (55)

1. Adini A., Kornaga T., Firoozbakht F., Benjamin L.E. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res. 62:2002;2749-2752
2. Allavena P., Sica A., Vecchi A., Locati M., Sozzani S., Mantovani A. The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol. Rev. 177:2000;141-149
3. Andreesen R., Osterholz J., Bross K.J., Schultz A., Luckenbach G.A., Lohr G.W. Cytoçoxic effector cell function at different stages of human monocyte-macrophage maturation. Cancer Res. 43:1983;5931-5936
4. Azenshtein E., Luboshits G., Shina S., Neumark E., Shahbazian D., Weil M., et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 62:2002;1093-1102
5. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 357:2001;539-545
6. Bronte V., Serafini P., Apolloni E., Zanovello P. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J. Immunother. 24:2001;431-446
7. Conti I, Dube C, Rollins BJ. Chemokine-based pathogenetic mechanisms in cancer, In Cancer and Inflammation, Novartis Foundation Symposium 256. Chichester, Wiley, 2004. p. 29-52
8. Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:2000;481-490
9. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 420:2002;860-867
10. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell. 112:2003;645-657
11. Crowther M., Brown N.J., Bishop E.T., Lewis C.E. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukoc. Biol. 70:2001;478-490
12. Curino A., Mitola D.J., Aaronson H., McMahon G.A., Raja K., Keegan A.D., et al. Plasminogen promotes sarcoma growth and suppresses the accumulation of tumor-infiltrating macrophages. Oncogene. 21:2002;8830-8842
13. Dinapoli M.R., Calderon C.L., Lopez D.M. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J. Exp. Med. 183:1996;1323-1329
14. Duyndam M.C., Hilhorst M.C., Schluper H.M., Verheul H.M., van Diest P.J., Kraal G., et al. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts. Am. J. Pathol. 160:2002;537-548
15. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3:2003;23-35
16. Grimshaw M.J., Balkwill F.R. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation - a potential mechanism. Eur. J. Immunol. 31:2001;480-489
17. Haghnegahdar H., Du J., Wang D., Stricter R.M., Burdick M.D., Nanney L.B., et al. The tumorigenie and angiogenic effects of MGSA/GRO proteins in melanoma. J. Leukoc. Biol. 67:2000;53-62
18. Herbeuval J.P., Lambert C., Sabido O., Cottier M., Fournel P., Dy M., et al. Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis. J. Natl. Cancer Inst. 95:2003;611-621
19. Hotchkiss K.A., Ashton A.W., Klein R.S., Lenzi M.L., Zhu G.H., Schwartz E.L. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorilase mediate human endothelial cell migration. Cancer Res. 63:2003;527-533
20. Ibe S., Qin Z., Schuler T., Preiss S., Blankenstein T. Tumor rejection by disturbing tumor stroma cell interactions. J. Exp. Med. 194:2001;1549-1559
21. IUIS/WHO Subcommittee on Chemokine Nomenclature. Chemokine/chemokine receptor nomenclature. Cytokine 2003, 21, 48-49
22. Klimp A.H., Hollema H., Kempinga C., van der Zee A.G., de Vries E.G., Daemen T. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res. 61:2001;7305-7309
23. Joseph I.B., Isaacs J.T. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. J. Natl. Cancer Inst. 90:1998;1648-1653
24. Larry M., Wahl H.K., Kleinman Tumor-associated macrophages as targets for cancer therapy. J. Natl. Cancer Inst. 90:1998;1583-1584
25. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammaiy tumors to malignancy. J. Exp. Med. 193:2001;727-740
26. Locati M., Deuschle U., Massardi M.L., Martinez F.O., Sironi M., Sozzani S., et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J. Immunol. 168:2002;3557-3562
27. Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56:1996;4625-4629
28. Leek R.D., Landers R.J., Harris A.L., Lewis C.E. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer. 79:1999;991-995
29. Mantovani A., Bottazzi B., Colotta F., Sozzani S., Ruco L. The origin and function of tumor-associated macrophages. Immunol. Today. 13:1992;265-270
30. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol. Today. 20:1999;254-257
31. Mantovani A., Locati M., Vecchi A., Sozzani S., Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22:2001;328-336
32. Majumder B., Biswas R., Chattopadhyay U. Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12. Int. J. Cancer. 97:2002;493-500
33. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 73:2003;209-212
34. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:2001;50-56
35. Mullins D.W., Burger C.J., Elgert K.D. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J. Immunol. 162:1999;6811-6818
36. Nesbit M., Schaider H., Miller T.H., Herlyn M. Low-level monocyte chernoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J. Immunol. 166:2001;6483-6490
37. Nowicki A., Szenajch J., Ostrowska G., Wojtowicz A., Wojtowicz K., Kruszewski A.A., et al. Impaired tumor growth in colony-stimulating factor 1 (CSF-l)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int. J. Cancer. 65:1996;112-119
38. Ohno S., Suzuki N., Ohno Y., Inagawa H., Soma Gen-Ichiro, Inoue M. Tumor-associated macrophages: foe or accomplice of tumor? Anticancer Res. 23:2003;4395-4410
39. Opdenakker C.F., Van Damme J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol. Today. 13:1992;463-464
40. Robinson S.C., Scott K.A., Wilson J.L., Thompson R.G., Proudfoot A.E., Balkwill F.R. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res. 63:2003;8360-8365
41. Rollins B. Chemokines and cancer. 1999;Humana Press, Totowa, NJ
42. Schioppa T., Uranchimeg B., Saccani A., Biswas S.K., Rapisarda A., Bernasconi S., et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198:2003;1391-1402
43. Schoppmann S.F., Birner P., Stockl J., Kalt R., Ullrich R., Caucig C., et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphoangiogenesis. Am. J. Pathol. 161:2002;947-956
44. Schutyser E., Struyf S., Proost P., Opdenakker G., Laureys G., Verhasselt B., et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J. Biol. Chem. 277:2002;24584-24593
45. Scotton C.J., Wilson J.L., Scott K., Stamp G., Wilbanks G.D., Fricker S., et al. Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res. 61:2001;4961-4965
46. Semenza A., Greeg L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88:2000;1474-1480
47. Sica A., Saccani A., Bottazzi B., Polentaratti N., Vecchi A., van Damme J., et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages. J. Immunol. 164:2000;762-767
48. Talks K.L., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., et al. The expression and distribution of the hypoxia-inducible factors HIF- 1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157:2000;411-421
49. van den Berg A., Visser L., Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am. J. Pathol. 154:1999;1685-1691
50. Wang J.M., Chertov O., Proost P., Li J.J., Menton P., Xu L., et al. Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NF-κB activation. Int. J. Cancer. 75:1998;900-907
51. Scarpino S., Stopacciaro A., Ballerini F., et al. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cell to release chemokines active in recruiting dendritic cells. Am J Pathol. 156:2000;831-837
52. Griffiths L., Binley K., Iqball S., et al. The macrophage-a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 7:2000;255-262
53. Carta L., Pastorino S., Melillo G., et al. Engineering of macrophages to produce IFN-. γ in response to hypoxia J Immunol. 166:2001;5374-5380
54. Bronte V., Serafini P., Mazzoni A., et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24:2003;302-306
55. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:2004;71-78